Metagenomi (MGX) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChart

MGX Stock Forecast


Metagenomi stock forecast is as follows: an average price target of $14.50 (represents a 757.99% upside from MGX’s last price of $1.69) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

MGX Price Target


The average price target for Metagenomi (MGX) is $14.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $22.00 to $7.00. This represents a potential 757.99% upside from MGX's last price of $1.69.

MGX Analyst Ratings


Buy

According to 3 Wall Street analysts, Metagenomi's rating consensus is 'Buy'. The analyst rating breakdown for MGX stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Metagenomi Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 21, 2024Mitchell KapoorH.C. Wainwright$7.00$3.30112.12%314.20%
Mar 28, 2024Maury RaycrofJefferies$22.00$11.0998.38%1201.78%
Row per page
Go to

The latest Metagenomi stock forecast, released on Aug 21, 2024 by Mitchell Kapoor from H.C. Wainwright, set a price target of $7.00, which represents a 112.12% increase from the stock price at the time of the forecast ($3.30), and a 314.20% increase from MGX last price ($1.69).

Metagenomi Price Target by Period


1M3M12M
# Anlaysts-12
Avg Price Target-$7.00$14.50
Last Closing Price$1.69$1.69$1.69
Upside/Downside-100.00%314.20%757.99%

In the current month, the average price target of Metagenomi stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Metagenomi's last price of $1.69. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 15, 2024H.C. WainwrightBuyBuyHold
Sep 04, 2024Cowen & Co.BuyBuyHold
Aug 21, 2024H.C. WainwrightBuyBuyHold
May 07, 2024H.C. Wainwright-BuyInitialise
Mar 28, 2024JefferiesBuyBuyHold
Row per page
Go to

Metagenomi's last stock rating was published by H.C. Wainwright on Oct 15, 2024. The company gave MGX a "Buy" rating, the same as its previous rate.

Metagenomi Financial Forecast


Metagenomi Revenue Forecast

Revenue
Avg Forecast
High Forecast
Low Forecast
# Analysts
Surprise %

Metagenomi's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. MGX's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Metagenomi EBITDA Forecast

# Analysts
EBITDA
Avg Forecast
High Forecast
Low Forecast
Surprise %

undefined analysts predict MGX's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Metagenomi's previous annual EBITDA (undefined) of $NaN.

Metagenomi Net Income Forecast

# Analysts
Net Income
Avg Forecast
High Forecast
Low Forecast
Surprise %

Metagenomi's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. MGX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Metagenomi SG&A Forecast

# Analysts
SG&A
Avg Forecast
High Forecast
Low Forecast
Surprise %

Metagenomi's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to MGX last annual SG&A of $NaN (undefined).

Metagenomi EPS Forecast

# Analysts
EPS
Avg Forecast
High Forecast
Low Forecast
Surprise %

According to undefined Wall Street analysts, Metagenomi's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to MGX previous annual EPS of $NaN (undefined).

MGX Forecast FAQ


Is Metagenomi a good buy?

Yes, according to 3 Wall Street analysts, Metagenomi (MGX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of MGX's total ratings.

What is MGX's price target?

Metagenomi (MGX) average price target is $14.5 with a range of $7 to $22, implying a 757.99% from its last price of $1.69. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Metagenomi stock go up soon?

According to Wall Street analysts' prediction for MGX stock, the company can go up by 757.99% (from the last price of $1.69 to the average price target of $14.5), up by 1201.78% based on the highest stock price target, and up by 314.20% based on the lowest stock price target.

Can Metagenomi stock reach $3?

MGX's average twelve months analyst stock price target of $14.5 supports the claim that Metagenomi can reach $3 in the near future.